Darya-Varia Laboratoria Tbk PT
IDX:DVLA

Watchlist Manager
Darya-Varia Laboratoria Tbk PT Logo
Darya-Varia Laboratoria Tbk PT
IDX:DVLA
Watchlist
Price: 1 700 IDR -0.29% Market Closed
Market Cap: 1.9T IDR
Section:
Wall Street Price Targets
Wall Street Price Targets
Revenue Forecast
Operating Income Forecast
Net Income Forecast
See Also
Price Target
Loading...
Revenue
Loading...
Operating Income
Loading...
Net Income
Loading...

Wall Street
Price Targets

DVLA Price Targets Summary
Darya-Varia Laboratoria Tbk PT

There are no price targets for DVLA.
DVLA Lowest Forecast
Wall Street Target
Not Available
DVLA Average Forecast
Wall Street Target
Not Available
DVLA Highest Forecast
Wall Street Target
Not Available
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Darya-Varia Laboratoria Tbk PT Competitors:
Price Targets
4887
Sawai Group Holdings Co Ltd
42% Upside
4578
Otsuka Holdings Co Ltd
28% Upside
AGY
Allergy Therapeutics PLC
92% Upside
MVP
Medical Developments International Ltd
26% Upside
4887
Sawai Group Holdings Co Ltd
42% Upside
4578
Otsuka Holdings Co Ltd
28% Upside
AGY
Allergy Therapeutics PLC
92% Upside
MVP
Medical Developments International Ltd
26% Upside
COPN
Cosmo Pharmaceuticals NV
76% Upside
SAN
Sanofi SA
35% Upside
688526
Wuhan Keqian Biology Co Ltd
29% Upside
E
EMCURE
Emcure Pharmaceuticals Ltd
18% Upside

Revenue
Forecast

Revenue Estimate
Darya-Varia Laboratoria Tbk PT

For the last 13 years the compound annual growth rate for Darya-Varia Laboratoria Tbk PT's revenue is 6%. The projected CAGR for the next 11 years is -5%.

6%
Past Growth
-5%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Darya-Varia Laboratoria Tbk PT

For the last 13 years the compound annual growth rate for Darya-Varia Laboratoria Tbk PT's operating income is 3%. The projected CAGR for the next 11 years is -2%.

3%
Past Growth
-2%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Darya-Varia Laboratoria Tbk PT

For the last 13 years the compound annual growth rate for Darya-Varia Laboratoria Tbk PT's net income is 2%. The projected CAGR for the next 11 years is -2%.

2%
Past Growth
-2%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

See Also

Summary
DVLA intrinsic value, competitors valuation, and company profile.
DCF Valuation
DVLA stock valuation using Discount Cash Flow valuation method.
Relative Valuation
DVLA stock valuation using valuation multiples.
Wall Street Estimates
DVLA price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
DVLA stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is DVLA's stock price target?
Not Available

DVLA doesn't have any price targets made by Wall Street professionals.

What is Darya-Varia Laboratoria Tbk PT's Revenue forecast?
Projected CAGR
-5%

For the last 13 years the compound annual growth rate for Darya-Varia Laboratoria Tbk PT's revenue is 6%. The projected CAGR for the next 11 years is -5%.

What is Darya-Varia Laboratoria Tbk PT's Operating Income forecast?
Projected CAGR
-2%

For the last 13 years the compound annual growth rate for Darya-Varia Laboratoria Tbk PT's operating income is 3%. The projected CAGR for the next 11 years is -2%.

What is Darya-Varia Laboratoria Tbk PT's Net Income forecast?
Projected CAGR
-2%

For the last 13 years the compound annual growth rate for Darya-Varia Laboratoria Tbk PT's net income is 2%. The projected CAGR for the next 11 years is -2%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 258,300+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.